Indaptus Therapeutics, Inc. (INDP) stock
INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.17+0.02 (+0.63%)
Close on Nov 13, 2026Market cap $422.38MP/E –Yield –
Indaptus Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Indaptus Therapeutics's enterprise value was $416.15M on Nov 11, 2026, against -$2.16M a year earlier. Over the last 5 years it ranged from -$18.16M to $416.15M, with a median of -$541.16K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $416.15M | – |
| 2025 | Dec 31, 2025 | -$1.05M | -199.2% |
| 2024 | Dec 31, 2024 | $1.06M | – |
| 2023 | Dec 29, 2023 | -$1.44M | – |
| 2022 | Dec 30, 2022 | -$16.69M | -551.9% |
| 2021 | Dec 31, 2021 | $3.69M | – |
See a number that looks wrong?